These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 9652843

  • 1. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):817-22. PubMed ID: 9652843
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):982-7. PubMed ID: 11704321
    [Abstract] [Full Text] [Related]

  • 3. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.
    Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K.
    Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1081-7. PubMed ID: 17398031
    [Abstract] [Full Text] [Related]

  • 4. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM, Gorla G, Gupta S, Garg M, Deore S, Runowicz CD, Fields AL, Goldberg GL, Anderson PS, Vikram B.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):702-6. PubMed ID: 12062615
    [Abstract] [Full Text] [Related]

  • 5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan 01; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 6. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS, Kim JS, Kim SY, Kim Ki, Cho MJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1247-53. PubMed ID: 12654434
    [Abstract] [Full Text] [Related]

  • 7. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS, Kim JH, Ahn SD, Lee SW, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1522-8. PubMed ID: 19231106
    [Abstract] [Full Text] [Related]

  • 8. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
    Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.
    Strahlenther Onkol; 2002 Jul 01; 178(7):378-85. PubMed ID: 12163992
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):966-71. PubMed ID: 22138462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
    Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Clarke-Pearson DL, Liao SY.
    J Clin Oncol; 1999 May 01; 17(5):1339-48. PubMed ID: 10334517
    [Abstract] [Full Text] [Related]

  • 13. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC, Tung SY, Leung TW, Sze WK, Wong VY, Lui CM, Yuen KK, O SK.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1254-64. PubMed ID: 12654435
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix.
    Grigsby P, Winter K, Komaki R, Marcial V, Eifel P, Doncals D, Stevens R, Rotman M, Gaffney D.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):51-7. PubMed ID: 12182974
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
    Husseinzadeh N, Shrake P, DeEulis T, Rowley K, Aron B.
    Gynecol Oncol; 1994 Mar 01; 52(3):326-31. PubMed ID: 8157190
    [Abstract] [Full Text] [Related]

  • 16. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
    Fishman A, Chiu JK, Girtanner RE, Dennis W, Carpenter LS, Lu HH, Woo SY, Kerley JM, Kaplan AL.
    Am J Clin Oncol; 1997 Aug 01; 20(4):342-7. PubMed ID: 9256886
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr 01; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.